• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ADENOSINE TRIPHOSPHATE Drug Record

  • Summary
  • Interactions
  • Claims
  • ADENOSINE TRIPHOSPHATE chembl:CHEMBL14249

    Alternate Names:

    ADENOSINE TRIPHOSPHATE
    ADENOSINE TRIPHOSPHATA
    FOSFOBION
    ADENOSINE 5'-TRIPHOSPHORATE
    TRIPHOSPHADEN
    GLUCOBASIN
    ADENOSINE 5'-TRIPHOSPHATE
    ADENYLPYROPHOSPHORATE
    MYOTRIPHOS
    [[[(2R,3R,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL]METHOXY-HYDROXY-PHOSPHORYL]OXY-HYDROXY-PHOSPHORYL]OXYPHOSPHONIC ACID
    TRIADENYL
    ADENYLPYROPHOSPHORIC ACID
    ADENOSINE 5'-TRIPHOSPHORIC ACID
    ADYNOL
    CARDENOSINE
    ADENOSINE 5' TRIPHOSPHATE
    TRIPHOSPHORIC ACID ADENOSINE ESTER
    5'-(TETRAHYDROGEN TRIPHOSPHATE) ADENOSINE
    ADEPHOS
    ({[({[(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYOXOLAN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL)OXY](HYDROXY)PHOSPHORYL}OXY)PHOSPHONIC ACID
    ADENOSINE-5'-TRIPHOSPHATE
    ADETOL
    STRIADYNE
    H4ATP
    ATP
    ATRIPHOS
    ATIPI
    5'-ATP
    [[[(2R,3R,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHOXY-HYDROXY-PHOSPHORYL]OXY-HYDROXY-PHOSPHORYL]OXYPHOSPHONIC ACID
    PHOSPHOBION
    pubchem.compound:5957
    drugbank:00171
    chembl:CHEMBL14249
    chemidplus:56-65-5
    rxcui:318

    Drug Info:

    Drug Type small molecule
    Drug Groups investigational
    Drug Groups nutraceutical
    Drug Categories adenine nucleotides
    Drug Categories adenosine triphosphate
    Drug Categories carbohydrates
    Drug Categories dietary supplements
    Drug Categories glycosides
    Drug Categories heterocyclic compounds, fused-ring
    Drug Categories nucleic acids, nucleotides, and nucleosides
    Drug Categories nucleotides
    Drug Categories purine nucleotides
    Drug Categories purines
    Drug Categories ribonucleotides
    Drug Categories supplements
    (0 More Sources)

    Publications:

    Adrián FJ et al., 2006, Allosteric inhibitors of Bcr-abl-dependent cell proliferation., Nat Chem Biol
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
    Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
    Xiao Z et al., 2011, P2Y11 impairs cell proliferation by induction of cell cycle arrest and sensitizes endothelial cells to cisplatin-induced cell death., J Cell Biochem
    Van Meter et al., 2006, Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas., Cancer
    Gardner et al., 2006, Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib., Clin. Pharmacol. Ther.
    Blume et al., 2006, Pharmacokinetic drug interaction profiles of proton pump inhibitors., Drug Saf
    Lage, 2006, MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance., Curr Drug Targets
    Fukui et al., 2007, Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients., Ther Drug Monit
    Gervasini et al., 2006, Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer., Cancer
    Hong TJ et al., 2013, Dynamic nucleotide-dependent interactions of cysteine- and histidine-rich domain (CHORD)-containing Hsp90 cochaperones Chp-1 and melusin with cochaperones PP5 and Sgt1., J Biol Chem
    Berger AL et al., 2005, Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain., Proc Natl Acad Sci U S A
    Chinnaiyan, 1999, The apoptosome: heart and soul of the cell death machine., Neoplasia
    Suchy et al., 2006, Bile salt excretory pump: biology and pathobiology., J. Pediatr. Gastroenterol. Nutr.
    Snow et al., 2007, Effect of thiazolidinediones on bile acid transport in rat liver., Life Sci.
    Thomas et al., 2006, ABCA12 is the major harlequin ichthyosis gene., J. Invest. Dermatol.
    Materna et al., 2006, RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells., Biochem. Biophys. Res. Commun.
    Girardin, 2006, Membrane transporter proteins: a challenge for CNS drug development., Dialogues Clin Neurosci
    Pinkett et al., 2007, An inward-facing conformation of a putative metal-chelate-type ABC transporter., Science
    Iliás A et al., 2002, Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6)., J Biol Chem
    Rau et al., 2006, High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations., Clin. Pharmacol. Ther.
    Li et al., 2007, Protective effects of hepatocellular canalicular conjugate export pump (Mrp2) on sodium arsenite-induced hepatic dysfunction in rats., Exp. Toxicol. Pathol.
    Westlake CJ et al., 2004, Identification and characterization of functionally important elements in the multidrug resistance protein 1 COOH-terminal region., J Biol Chem
    Pierre F et al., 2011, Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer., J Med Chem
    Badeau et al., Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women., Menopause
    Porchay et al., 2006, ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study., Obesity (Silver Spring)
    Zarubica et al., 2007, ABCA1, from pathology to membrane function., Pflugers Arch.
    Folkes AJ et al., 2008, The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer ., J Med Chem
    Starai et al., 2002, Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine., Science
    Schuler et al., Enhanced biological phosphorus removal from wastewater by biomass with different phosphorus contents, Part II: Anaerobic adenosine triphosphate utilization and acetate uptake rates., Water Environ. Res.
    Yang et al., 2007, Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel., Eur. J. Heart Fail.
    Bryan et al., 2007, ABCC8 and ABCC9: ABC transporters that regulate K+ channels., Pflugers Arch.
    Zhao et al., 2006, Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion., Coron. Artery Dis.
    Sauna ZE et al., 2004, The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1)., Mol Pharmacol
    Nakamura et al., 2007, Differential effects of etomidate and midazolam on vascular adenosine triphosphate-sensitive potassium channels: isometric tension and patch clamp studies., Anesthesiology
    Bienengraeber et al., 2006, Mechanism of cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel activation by isoflurane in a heterologous expression system., Anesthesiology
    Tanaka et al., 2007, Isoflurane activates sarcolemmal adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells: a role for protein kinase A., Anesthesiology
    Walther et al., 2007, Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease., Circulation
  • ADENOSINE TRIPHOSPHATE   AFG3L2

    Interaction Score: 2.99

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ACSS1

    Interaction Score: 2.99

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ASNA1

    Interaction Score: 2.99

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   PPP5C

    Interaction Score: 1.99

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23184943


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ACSL1

    Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   GRK2

    Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   AMHR2

    Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   NAE1

    Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   GRK3

    Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCG1

    Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16842213 16902423 16876126 17117613 17158291


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   CSNK2B

    Interaction Score: 1.0

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21174434


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ACVR1B

    Interaction Score: 0.75

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   SLC25A4

    Interaction Score: 0.66

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17210842


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ACSS2

    Interaction Score: 0.62

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    12493915 17139284 14704009 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ACVRL1

    Interaction Score: 0.6

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ASNS

    Interaction Score: 0.6

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ADCY1

    Interaction Score: 0.6

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ASS1

    Interaction Score: 0.5

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCA1

    Interaction Score: 0.5

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17224860 17135600 16858612


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCC6

    Interaction Score: 0.5

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11880368


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   P2RY11

    Interaction Score: 0.5

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? True
    Direct Interaction? False

    PMIDs:
    21503959


    Sources:
    DrugBank GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   P2RX1

    Interaction Score: 0.5

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? True
    Direct Interaction? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   ABL2

    Interaction Score: 0.44

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:

    PMIDs:
    11752352 17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   NT5C2

    Interaction Score: 0.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   CDK15

    Interaction Score: 0.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCC9

    Interaction Score: 0.36

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16829188 16897043 16845255


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   P2RX4

    Interaction Score: 0.33

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? True
    Direct Interaction? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   ARAF

    Interaction Score: 0.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCB11

    Interaction Score: 0.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16819395 17126857


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCC8

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17325510 16897043 16931986 17457130


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   P2RY13

    Interaction Score: 0.25

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? True

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   GPR17

    Interaction Score: 0.25

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? True

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   P2RY4

    Interaction Score: 0.25

    Interaction Types & Directionality:
    agonist (activating)
    antagonist (inhibitory)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? True
    Direct Interaction? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   P2RX3

    Interaction Score: 0.2

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? True
    Direct Interaction? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   P2RY1

    Interaction Score: 0.2

    Interaction Types & Directionality:
    agonist (activating)
    antagonist (inhibitory)

    Interaction Info:
    Specific Action of the Ligand Partial agonist
    Endogenous Drug? True
    Specific Action of the Ligand Antagonist

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   ITPR1

    Interaction Score: 0.2

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:
    Interaction Context cytosolic
    Specific Action of the Ligand None
    Details of Interaction < mM range

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   RYR3

    Interaction Score: 0.2

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:
    Interaction Context cytosolic
    Specific Action of the Ligand None
    Details of Interaction endogenous; mM range

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   TRPM4

    Interaction Score: 0.17

    Interaction Types & Directionality:
    blocker (inhibitory)
    inhibitor (inhibitory)

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? True

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   TNK2

    Interaction Score: 0.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ACVR1

    Interaction Score: 0.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   P2RY2

    Interaction Score: 0.11

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? True
    Direct Interaction? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   PRKAA1

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   APAF1

    Interaction Score: 0.09

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10935465 17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   P2RX7

    Interaction Score: 0.09

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction? False
    Endogenous Drug? True
    Specific Action of the Ligand Agonist

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   RYR2

    Interaction Score: 0.08

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:
    Interaction Context cytosolic
    Specific Action of the Ligand None
    Details of Interaction endogenous; mM range

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   ABL1

    Interaction Score: 0.08

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:

    PMIDs:
    16415863 11752352 17139284 17016423


    Sources:
    DTC DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCC2

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17112803 17467962 16876126


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCC4

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    14978246


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   CFTR

    Interaction Score: 0.07

    Interaction Types & Directionality:
    cofactor (activating)

    Interaction Info:

    PMIDs:
    15623556


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   RYR1

    Interaction Score: 0.06

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:
    Interaction Context cytosolic
    Specific Action of the Ligand None
    Details of Interaction endogenous; mM range

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ADENOSINE TRIPHOSPHATE   HSPA8

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ADENOSINE TRIPHOSPHATE   ALK

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17139284 17016423


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   CSNK2A1

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21174434


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCC1

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15459206


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   AKT1

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17041888


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   ABCB1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16890580 16944963 16842213 17417072 17120199


    Sources:
    DrugBank

  • ADENOSINE TRIPHOSPHATE   PIK3CA

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18754654


    Sources:
    DrugBank

  • DrugBank: DB00171

    • Version: 5.1.7

    Alternate Names:
    ATP DrugBank Drug Name
    56-65-5 CAS Number
    Atriphos Drug Brand

    Drug Info:
    Drug Type small molecule
    Drug Groups investigational
    Drug Groups nutraceutical

    Publications:
    Rau et al., 2006, High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations., Clin. Pharmacol. Ther.
    Li et al., 2007, Protective effects of hepatocellular canalicular conjugate export pump (Mrp2) on sodium arsenite-induced hepatic dysfunction in rats., Exp. Toxicol. Pathol.
    Materna et al., 2006, RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells., Biochem. Biophys. Res. Commun.

  • DTC: ADENOSINE TRIPHOSPHATE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL14249 ChEMBL Drug ID

    Drug Info:

    Publications:
    Adrián FJ et al., 2006, Allosteric inhibitors of Bcr-abl-dependent cell proliferation., Nat Chem Biol

  • GuideToPharmacology: 135651446

    • Version: 29-September-2020

    Alternate Names:
    ATP GuideToPharmacology Ligand Name

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL14249

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21